First-In-Human Study of Apramycin

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
This is a first-in-human study to assess the safety, tolerability and pharmacokinetics of escalating single doses of apramycin. This trial will be conducted as a single ascending dose trial in up to 5 sequential dose cohorts (group-comparison). Each cohort will consist of 8 healthy subjects, 6 will receive apramycin and 2 placebo.
Epistemonikos ID: 9a043d8d1b694d583c9c0145471d778e9c587973
First added on: Apr 22, 2023